Cited by 754Alcohol Consumption and Health EffectsGut microbiota and healthLiver Disease and Transplantation

The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.

Gut–Liver Axis in Alcoholic Liver Disease

Open access

Szabo, Gyongyi·2015·Gastroenterology

DOI 10.1053/j.gastro.2014.10.042PMC PMC4274189

Open this paper in CoChat — free account

Abstract

Alcoholic liver disease (ALD) has been among the leading causes of cirrhosis and liver-related death worldwide for decades. Early discoveries in alcoholic liver disease identified increased levels of bacterial endotoxin in the portal circulation, suggesting a role for gut-derived toxins in ALD. Indeed, alcohol consumption can disrupt the intestinal epithelial barrier and result in increased gut permeability that increasingly is recognized as a major factor in ALD. Bacterial endotoxin, lipopolysaccharide, is a prototypic microbe-derived inflammatory signal that contributes to inflammation in ALD through activation of the Toll-like receptor 4. Recent studies also have shown that alcohol consumption is associated with alterations in the gut microbiome, and the dysbalance of pathogenic and commensal organisms in the intestinal microbiome may contribute to the abnormal gut-liver axis in ALD. Indeed, bacterial decontamination improves ALD both in human and animal models. This short review summarizes recent findings and highlights emerging trends in the gut-liver axis relevant to ALD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2014.10.042

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,820
CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
Wright, S. D., Ramos, R., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,996
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
The acute phase response
Baumann, H., & Gauldie, J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90137-6 · Cited by 2,907
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
The Liver as an Immunological Organ
Racanelli, V., & Rehermann, B. (2006) · Hepatology · doi:10.1002/hep.21060 · Cited by 1,377
Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
Dapito, D. H., Mencin, A., Gwak, G.-Y., Pradere, J.-P., Jang, M.-K., Mederacke, I., Caviglia, J. M., Khiabanian, H., Adeyemi, A., Bataller, R., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.007 · Cited by 1,346
Bile acids and the gut microbiome
Ridlon, J. M., Kang, D. J., Hylemon, P. B., & Bajaj, J. S. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000057 · Cited by 1,329
Rifaximin Treatment in Hepatic Encephalopathy
Bass, N. M., Mullen, K. D., Sanyal, A., Poordad, F., Neff, G., Leevy, C. B., Sigal, S., Sheikh, M. Y., Beavers, K., Frederick, T., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907893 · Cited by 1,300
Interactions Between the Intestinal Microbiome and Liver Diseases
Schnabl, B., & Brenner, D. A. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.020 · Cited by 971

Show all 81 references

Sorted by citations

Items 701–754 of 754

Acute-on-chronic liver failure
Rodgers, K. G., Swann, R. E., & Hart, R. (2025) · BJA Education · doi:10.1016/j.bjae.2025.06.001
ABC-12: exploring the microbiome in patients with advanced biliary tract cancer in a first-line study of durvalumab (MEDI4736) in combination with cisplatin/gemcitabine
Vrana, E., Timmins, H., Osborne, A., Cox, R., Wasan, H. S., Ma, Y. T., Arora, A., Faluyi, O. O., Gillmore, R., Corrie, P. G., et al. (2025) · Future Oncology · doi:10.1080/14796694.2025.2539018
Propionylated High-Amylose Maize Starch Protects Gut Barrier Function Via Gpr41/43-Il-22-Stat3 Signaling to Alleviate Alcoholic Liver DiseasePreprint
Liu, H., Guo, M., Wang, H., Wang, M., Yan, S., Chen, W., Song, Y., Zhao, Y., Mackay, C. R., Xu, Q., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5400494
Propionylated High-Amylose Maize Starch Protects Gut Barrier Function Via Gpr41/43-Il-22-Stat3 Signaling to Alleviate Alcoholic Liver DiseasePreprint
Liu, H., Guo, M., Wang, H., Wang, M., Yan, S., Chen, W., Song, Y., Zhao, Y., Mackay, C. R., Xu, Q., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5400262
Anatomy and Physiology of the Biliary Epithelium
Hall, C., Glaser, S. S., & Alpini, G. D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.01004-4
Lactobacillus helveticus ZJUIDS12 Rescues Alcohol‐Associated Liver Disease via a Clostridium butyricum ‐Regulated Intestinal Reg3γ Pathway
Ding, Q., Cao, F., Lai, S., Yu, J., Zeng, Y., Valencak, T. G., Zhang, S., Zhang, X., Dou, X., Li, S., et al. (2025) · Food Frontiers · doi:10.1002/fft2.70158
Wolfberry prevented liver damage caused by anti-tuberculosis drugs associated with the YAP1/FXR pathway through gut microbiota
Wang, D., Xiong, Y., Liu, Z., Song, X., Liu, J., Gong, Y., Li, Z., & Shi, X. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1700408
Additional file 1 of Gut microbiome-targeted therapies in liver cirrhosis: a protocol for systematic review and meta-analysis
Jiang, H., Peng, Y., Zhang, W., Chen, Y., Jiang, Q., & Zhou, Y. (2022) · Figshare · doi:10.6084/m9.figshare.20742259
A Multi-Mineral Intervention Improves Intestinal Permeability in Patients with Ulcerative Colitis: Results from a 90-Day Pilot TrialPreprint
Aslam, M. N., Turgeon, D. K., McClintock, S. D., Allen, R., Sen, A., & Varani, J. (2026) · medRxiv · doi:10.64898/2026.01.28.26345064
Interleukin-38: A Candidate Biomarker for Disease Severity in Advanced Steatotic Liver Disease
Wagner, V., Mederer, M., Enrich, B., Cibulkova, V., Piater, J., Zollner, A., Giquel-Fernandes, R., Tilg, H., & Effenberger, M. (2026) · Cells · doi:10.3390/cells15030280
Lipopolysaccharide and imiquimod stimulation of potential immune biomarkers in whole blood predict alcohol use disorder risk based on AUDIT scores
Balan, I., Lopez, A. G., Gilmore, T. A., Bremmer, M. P., O’Buckley, T. K., Xia, K., Hendershot, C. S., & Morrow, A. L. (2026) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.70236
Understanding liver and digestive diseases: a paved road to improve diagnosis, management, and treatment
Bergheim, I., Cadranel, J. F. D., Chen, J., Ding, W., Eferl, R., García‐Ruiz, C., Jaeschke, H., Kazerouni, F., Lonardo, A., Mann, D. A., et al. (2026) · Exploration of Digestive Diseases · doi:10.37349/edd.2026.1005110
Epistemic compression in large language model explanations of the gut–liver axis
Sun, M., Zang, D., Zhou, H., Che, Y., & Chen, J. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1773593
Exploring potential biomarkers and constructing prediction models of osimertinib based on a retrospective study
Cui, L., Tang, M., Liang, S., Bu, C., Yun, Y., Gao, S., Wang, Z., & Tao, X. (2026) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-025-03940-5
Longitudinal assessment of the circulating cytokine profile of severe alcohol-associated hepatitis
Tornai, D., Mitchell, M. C., McClain, C. J., Dasarathy, S., BARTON, B. A., & Szabó, G. (2026) · Hepatology · doi:10.1097/hep.0000000000001743
Systemic Consequences of Chronic Ethanol Intake: From Microbiome Shifts to Metabolic Impairment
Ganjayi, M. S., Krauss, T. A., Demster, G. E., Park, S., Anspach, G., Anthony, S., Wang, S., Tranter, M., Helsley, R. N., & Baumann, C. W. (2026) · Comprehensive physiology · doi:10.1002/cph4.70132
Mécanismes inflammatoires liés à la consommation chronique d'alcool : de la translocation bactérienne aux monocytes.
Donnadieu‐Rigole, H. (2016) · doi:10.70675/f90f0a83z763ez43e3z9e94z3003045bae48
Microplastics and Liver Health: A PRISMA Systematic Review of Hepatic Injury Mechanisms and Carcinogenic Potential
Aydın, M. F. (2026) · Medical Science and Discovery · doi:10.36472/msd.v13i3.1350
Le microbiote intestinal comme cible thérapeutique dans la maladie alcoolique du foie : implication des acides biliaires et de la pectine
Ciocan, D. M. (2018) · theses.fr (ABES) · doi:10.70675/f76b0335zd8baz4b14za916zd8a1cbd3325c
Étude des effets des acides gras oméga-3 et de nouvelles bactéries probiotiques pour contrer les désordres associés à l'obésité au niveau métabolique et intestinal
Barz, M. L. (2017) · theses.fr (ABES) · doi:10.70675/d1f0a7a2z6eadz445dzb191za197a6f08824
Étude du lien entre maladie alcoolique du foie, microbiote intestinal et acides biliaires : rôles spécifiques de la pectine et du récepteur aux acides biliaires TGR5
Spatz, M. (2018) · theses.fr (ABES) · doi:10.70675/b092156fz2e11z40fbza4cbz9262830ab0c1
Hétérogénéité et mécanismes d’initiation de la réponse humorale dans les tumeurs du sein et de l’ovaire
Couillault, C. (2019) · theses.fr (ABES) · doi:10.70675/843d4729zb881z4e85z9bf5z1adbd72f3e7a
The role of Traditional Chinese Medicine in the management of liver disease: targeting gut microbiome
Zhang, Q., Li, H., Yu, F., Gao, M., Wang, Y., Xin, S., Yang, J., Wang, Z., Xiang, L., Ru, Q., et al. (2026) · Chinese Medicine · doi:10.1186/s13020-026-01395-z
Letter: Attempted Validation of Villin‐1 as a Gut Barrier Marker in Decompensated Cirrhosis—Potential Confounding by Tubular Injury and Aetiology. Authors' Reply
Tornai, D., & Papp, M. (2026) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70689
Serum amyloid A in the gut-liver axis: Implications for alcohol-associated pathology
Zhong, W., Weinman, S. A., & Tikhanovich, I. (2026) · Alcohol · doi:10.1016/j.alcohol.2026.04.003
The Role of MicroRNA Networks in Alcohol-associated Liver Disease
Park, S. H., & Seo, W. (2026) · Journal of Digestive Cancer Research · doi:10.52927/jdcr.2026.14.1.67
Hepatocyte-Specific Deletion of Betaine-Homocysteine Methyltransferase Disrupts Methionine Metabolism and Promotes the Spontaneous Development of Hepatic Steatosis
Ramachandran, R., Perumal, S. K., Bellamkonda, R., Mahalingam, S., Fisher, K. W., Quadros, R. M., Gurumurthy, C. B., Arumugam, M. K., Rasineni, K., & Kharbanda, K. K. (2026) · Biomolecules · doi:10.3390/biom16040606
Quercetin Alleviates Intestinal and Liver Dysfunction Induced by Hypoxia in a Microphysiological System
Liu, Z., Li, L., Yang, T., Qin, J., & Wang, Y. (2026) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c02045
Yajieshaba extract improves alcohol‑induced liver injury by regulating hepatic lipid metabolism and gut microbiota
Liping, Y., Xingzhi, Y., Jie, T., & Xiaohua, D. (2026) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-026-05421-3
Diet-Derived Trimethylamine N-Oxide (TMAO) Pathway Disruption in Patients with Concurrent Alcohol Use Disorder and Smokers Persists After Alcohol Detoxification
Erdoğan, B. R., Aksoyalp, Z. Ş., Hasip, Ç., Bağcı, B., & Aksun, S. (2026) · Journal of Basic and Clinical Health Sciences · doi:10.30621/jbachs.1862944
Lactobacillus reuteri targets farnesoid X receptor-dependent bile acid homeostasis to ameliorate alcoholic liver disease
Yuan, S., Liu, Y., Gao, P., Sun, J., Wang, Y., Du, Z., Lei, J., Hong, J., Xh, F., Tu, P., et al. (2026) · The ISME Journal · doi:10.1093/ismejo/wrag153
Akkermansia muciniphila Alleviates Enterococcus faecalis-Exacerbated Alcoholic Liver Injury by Modulating Gut Microbiota and Barrier Function
Sui, X., Feng, S., Wang, W., Zhang, X., Liu, Y., & Peng, N. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125474
Chronic Intermittent Ethanol Exposure Produces Sex- and Tissue-Specific Metabolomic Signatures Across the Gut-Liver Axis in Adult MicePreprint
Pollak, J., Cannady, R., Wang, B., & Maldonado‐Devincci, A. M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.14.732186
Hepatic, oxidative, and immunological alterations in adults with concomitant Schistosoma mansoni infection and alcohol abuse in an endemic area of Cameroon
Yimgoua, E. S., Nkondo, E. T., Femoe, U. M., Fassi-Kadji, J. B., Kenfack, M. C., Feussom, N. G., Vázquez, S., Tchuenté, L.-A. T., Sotillo, J., & Jatsa, H. B. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-13894-3
Reprogramming gut microbiota and targeting CXCL1: The multifaceted mechanism of PLP1 in ameliorating alcohol-induced liver disease
Yang, Z., Lv, Q., Xu, Q., Chen, Y., Yang, Y., Li, Z., Che, H., Wang, G., Wei, W., Wu, J., et al. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.06.057
Microbiome-Targeted Modulation in Renal Transplantation
Hau, H. M., Jahn, N., Karitnig, R., Hasenhütl, S. M., Sucher, R., Stiegler, P., & Laudi, S. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15145648
L-theanine combined with epigallocatechin gallate to ameliorate alcoholic liver disease in mice by regulating the intestinal flora and activating the PPARα/FABP1/GPX4 pathway to inhibit ferroptosis
Fu, J., Yan, F., Qu, D., Wang, L., Chen, X., Pu, G., Yin, W., & Hu, C. Y. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.109552
Research Progress on the Mechanisms Underlying the Amelioration of Alcoholic Liver Disease by Major Functional Components of Ginseng
Zhang, J., Lu, S., Huang, R., Ge, W., Liu, S., Wang, M., & Chen, Z. (2026) · Food Reviews International · doi:10.1080/87559129.2026.2711909
Gut–Liver Axis Dysfunction in Alcohol-Associated Liver Disease and the Potential Role of Sheep Yogurt: A Scoping Review and Mechanistic Framework
Wu, Y., Zhao, Y., Yao, W., Yang, Y., Bai, H., Bao, S., Li, X., & Song, Y. (2026) · Nutrients · doi:10.3390/nu18152549
A comprehensive review of Nostoc commune polysaccharides: Preparation methods, structural characteristics, health benefits, and applications
Xu, X., Zhang, M., Yang, D., Fu, L., Wu, L., & Wang, M. (2026) · Algal Research · doi:10.1016/j.algal.2026.104879
Precision treatment and frontier advances of glycyrrhizin preparations in drug-induced liver injury (DILI)
Qiu, D., Gao, Z., Zhang, L., Ma, T., Wei, X., Zhang, Z., Cao, W., Li, X., Wang, S., Deng, W., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1890794
Hepatic stellate cells in alcoholic liver cirrhosis: mechanisms of fibrogenesis, plasticity, and fibrosis reversal
Raj, A., & Kosey, S. (2026) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-026-00644-8
Protective effects of Bacillus clausii against Amoxicillin-induced hepatic injury are associated with Attenuation of LPS–TLR4–NF-κB signalling
El‐Shenawy, N. S., Tawfik, N. M., Fouad, A. S., & El-Fahla, N. A. (2026) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-026-05210-7
Microbiome and Diseases: Steatotic Liver Disease
Bergheim, I., & Schneider, K. M. (2026) · Springer eBooks · doi:10.1007/978-3-032-26410-7_17
Virtual screening of Kv1.3 inhibitors and investigation of their molecular mechanisms in alleviating alcoholic liver injury in mice
Zhen, W.-J., Ye, J.-Q., Xia, G., Chen, X.-X., Tian, Y.-Y., Chen, S., Wang, M.-Q., Jia, L.-X., Zhang, Q., Wang, Y.-T., et al. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119310
Liver-centric strategies for immune enhancement: an evidence-based review of the gut–liver axis, metabolism, lifestyle, and vaccination
Kim, H., Yoo, J., Kim, S. G., & Kim, Y. J. (2026) · Journal of Korean Medical Association · doi:10.5124/jkma.26.0087
Polysaccharides from Chinese Baijiu by-products: Structural remodeling, cascade valorization, and functional food applications: A review
Feng, Y., Suo, K., Yang, Z., Wen, C., & Zhang, J. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.154713
Dietary Prickly Ash Seed Meal Suppresses Hepatic Lipogenesis and Improves Fillet Fatty Acid Profiles in Grass Carp ( Ctenopharyngodon idella )
Zhang, Y., Sherzada, S., Wang, P., & Zhou, J. (2026) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/jpn.70118
Structural characterization of an Alhagi honey polysaccharide and its activity against alcoholic fatty liver disease through the AMPK/PI3K–Akt/NF-κB signaling pathway
Wang, Y., Zheng, D., Li, Z., Chen, S., Zhao, C., Gan, Z., Li, J., Shen, J., & Chang, J. (2026) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2026.125919
Pectin alleviates alcohol-associated liver disease partly through cell-type-specific aryl hydrocarbon receptor signaling in female mice.
Hu, W.-C., Schlecht-louf, G., Vielhescaze, C., Trainel, N., Jouvanceau, S., Desmons, A., Mercier-Nomé, F., Viel, S., Coulibaly, A. S. K., Perrin, C., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.118085
The liver–gut–bone axis in hepatic osteodystrophy: mechanisms, clinical evidence and therapeutic perspectives
张良平, Jiang, T., Cao, R., Han, L., & Ni, L. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1935323
Clinical associations of zonulin plasma levels -marker of intestinal permeability- in patients with alcohol use disorder admitted for inpatient treatment
Khaled, H., Casado‐Carbajo, J., García‐Calvo, X., Hernández‐Rubio, A., López-Casas, J., Leis, A., Morán, T., Zuluaga, P., Muga, R., & Fuster, D. (2026) · Alcohol · doi:10.1016/j.alcohol.2026.107459
Vinegar polyphenol extract alleviates alcohol-induced liver injury through suppressing the hepatic MAPK signaling pathway and restoring gut microbiota homeostasis and short-chain fatty acid generation in male mice
Liu, Y., Qiu, Y., Li, D., Zhai, S., Xia, T., & Wang, M. (2026) · Food & Function · doi:10.1039/d6fo02941h
Dietary context and ethanol-related injury in preclinical models: A contemporary systematic review of predominantly obesogenic diets and liver outcomes
Agbonifo, W. O., Chimezie, J., Amoo, Z. A., Chukwukaeme, C., Francis, H. O., Awoleye, M. O., & Adedeji, T. G. (2026) · PLoS ONE · doi:10.1371/journal.pone.0352561

Authors: Szabo, G.
Venue: Gastroenterology
Publisher: Elsevier BV
Published: 2015-01
Volume: 148
Issue: 1
Pages: 30-36
ISSN: 0016-5085 (ISSN-L)
DOI: 10.1053/j.gastro.2014.10.042
PMC: PMC4274189
OpenAlex: W2034801500
Cited by: 754
References: 81
Citations by year: 2026: 64 · 2025: 67 · 2024: 72 · 2023: 67 · 2022: 89 · 2021: 77 · 2020: 63 · 2019: 59 · 2018: 67 · 2017: 49 · 2016: 51 · 2015: 28
FWCI: 6.05
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Gastroenterology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
Funders: National Institute on Alcohol Abuse and Alcoholism (AA021907, AA017729, AA010744)
Topics: Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Keywords: alcoholic liver disease, gut-liver axis, bacterial endotoxin, lipopolysaccharide, intestinal permeability, intestinal epithelial barrier, TLR4, gut microbiota, bacterial decontamination, liver cirrhosis, inflammation
MeSH terms: Animals, Bacteria, Humans, Intestinal Mucosa, Intestines, Liver, Liver Diseases, Alcoholic, Permeability, Prognosis, Signal Transduction, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Gut–Liver Axis in Alcoholic Liver Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks